A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cedars-Sinai Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
Centre Oscar Lambret
University Health Network, Toronto
Guangdong Provincial People's Hospital
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
St. Jude Children's Research Hospital
Children's Oncology Group
Children's Oncology Group
Mayo Clinic
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
First Affiliated Hospital of Zhejiang University
Mayo Clinic
University of Michigan Rogel Cancer Center
University Hospital, Bonn
Shanghai Zhongshan Hospital
Institut Claudius Regaud
University of Iowa
Shantou University Medical College
Mayo Clinic
Swiss Cancer Institute
Pusan National University Hospital
Eye & ENT Hospital of Fudan University
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Melanoma Institute Australia
Washington University School of Medicine
Fondazione Ricerca Traslazionale
Second Affiliated Hospital, School of Medicine, Zhejiang University
Women's Hospital School Of Medicine Zhejiang University
Peking University Cancer Hospital & Institute
Weill Medical College of Cornell University
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
Peking Union Medical College Hospital
First Affiliated Hospital of Guangxi Medical University
The First Affiliated Hospital of Guangzhou Medical University
Zhejiang Cancer Hospital
Zhongda Hospital
Dana-Farber Cancer Institute
Sun Yat-sen University